Slotkoff A T, Radulovic D A, Clauw D J
Veteran Affairs Palo Alto Health Care System, CA, USA.
Scand J Rheumatol. 1997;26(5):364-7. doi: 10.3109/03009749709065700.
Fibromyalgia (FM) patients often report a high frequency of non-musculoskeletal symptoms, including those suggestive of multiple chemical sensitivity (MCS) syndrome. The objective of this pilot study was to determine the prevalence of MCS in FM patients from a university-based rheumatology practice. Self-report questionnaires were administered to determine the presence of MCS, utilizing the criteria from a recent study of the immunologic profile of patients with this disorder. Patients also responded "yes" or "no" to the presence of 48 FM-related symptoms. Thirty-three of 60 patients with FM met the criteria for MCS. Eleven of these patients also fulfilled more restrictive criteria, requiring a "higher degree" of chemical sensitivity. The symptoms and substances most frequently cited were similar to those reported in other studies of MCS. FM patients with and without MCS did not differ in other symptomatology. MCS may represent an additional symptom complex within the spectrum of FM.
纤维肌痛(FM)患者常报告非肌肉骨骼症状的高发生率,包括那些提示多重化学敏感性(MCS)综合征的症状。这项初步研究的目的是确定一所大学风湿病诊所中FM患者的MCS患病率。使用近期一项关于该疾病患者免疫特征研究的标准,通过自我报告问卷来确定MCS的存在。患者还对48种与FM相关的症状是否存在回答“是”或“否”。60例FM患者中有33例符合MCS标准。其中11例患者还满足更严格的标准,即需要“更高程度”的化学敏感性。最常提及的症状和物质与其他MCS研究中报告的相似。有和没有MCS的FM患者在其他症状方面没有差异。MCS可能代表FM范围内的另一种症状复合体。